Advertisement

Topics

Stockholders Endorse venBio’s Case for Meaningful Change at Immunomedics

12:00 EST 3 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Preliminary Results Indicate Stockholders Have Elected ALL FOUR of venBio’s Independent, Highly-qualified Nominees venBio Select Advisor LLC (“venBio”), the beneficial owner of approximately 10.5 million shares, or 9.9...

Other Sources for this Article

Investor
Okapi Partners LLC
Bruce H. Goldfarb / Lydia Mulyk, 212-297-0720 or Toll-free 855-305-0857
info@okapipartners.com
or
Media:
Sloane & Company
Dan Zacchei / Joe Germani, 212-486-9500
dzacchei@sloanepr.com / jgermani@sloanepr.com

NEXT ARTICLE

More From BioPortfolio on "Stockholders Endorse venBio’s Case for Meaningful Change at Immunomedics"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...